Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01782456 · ClinicalTrials.gov registry record · NA

Tolerance of an Oral Nutritional Supplement(ONS)

A NA study, sponsored by Abbott Nutrition.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT01782456: Completed NA study, sponsored by Abbott Nutrition.

NCT01782456 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01782456, a NA study, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The objective of this study is to capture information on gastrointestinal tolerance (GI) of an oral nutritional supplement containing a new protein blend in healthy children aged ≥ 3 to ≤ 10 years.

Primary Outcome

Self-reported Questionnaire

Interventions

  • OTHER Study Oral Nutritional Supplement

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2013-03
Est. Completion 2013-04
Phase NA
Abbott Nutrition

89 total trials

What the finished NCT01782456 record still lists

NCT01782456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Study Oral Nutritional Supplement is the first listed.

NCT01782456 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01782456 about?

NCT01782456 is a clinical study titled "Tolerance of an Oral Nutritional Supplement(ONS)". The objective of this study is to capture information on gastrointestinal tolerance (GI) of an oral nutritional supplement containing a new protein blend in healthy children aged ≥ 3 to ≤ 10 years.

What is the current status of trial NCT01782456?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2013-03. Estimated completion is 2013-04.

What interventions are being tested in trial NCT01782456?

The interventions under investigation include: Study Oral Nutritional Supplement (OTHER).

Who is sponsoring clinical trial NCT01782456?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01782456's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01782456, the US trial registry maintained by the National Library of Medicine. NCT01782456 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.